Neovacs, a French Biotechnology company, develops therapeutic vaccines for the treatment of autoimmune, inflammatory diseases aand invests in innovative companies (Biotech and Medtech).
Looking for a particular NEOVACS employee's phone or email?
The NEOVACS annual revenue was $750000 in 2026.
Olivier Dhellin is the director pharmaceutical development of NEOVACS.
13 people are employed at NEOVACS.
NEOVACS is based in Suresnes, Île-de-France.
The NAICS codes for NEOVACS are [54171, 541, 54, 541713, 5417].
The SIC codes for NEOVACS are [87, 873].